check quantity

Real-World Evidence (RWE)

Real-World Evidence (RWE) has become an integral component of drug and medical device development, as well as of Health Economics & Outcomes Research (HEOR). Serving as a complement to conventional randomized clinical trials (RCTs), Real-World Evidence collects supporting outcomes and safety data beyond RCTs, that provide a more comprehensive view of a product's real-life therapeutic and economic value to patients, payers, providers and sponsors. With the right data and analytics support, Real-World Evidence informs a common understanding of a drug or device efficacy and safety profile that is used by multiple healthcare stakeholders to drive decisions.

部件号 RealWorldEvidence





详情 信息

Our Real-World Evidence solution, leveraging TIBCO Spotfire®, accelerates time to insight with pre-built analysis modules that create the possibility to conduct an end-to-end analysis in one place:

  • Bring multiple data sources into one area
  • Assess background safety signals
  • Create relevant subsets of data for refined analysis
    (e.g., propensity matched cohorts)
  • Predictive analytics via machine learning and statistical
    methods to address:
    • Medication adherence
    • Patient outcomes
    • Comparative effectiveness
  • Archive results and work projects for easy retrieval later